Insiders Sino Biopharmaceutical Limited

Stocks

1177

KYG8167W1380

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:39:02 15/06/2026 pm IST			5-day change	1st Jan Change
4.780 ^HKD	+1.70%		+5.74%	-22.49%

06:53am	Sino Biopharmaceutical Plans HK$2 Billion Stock Buyback	MT
30/05	Sino Biopharmaceutical Limited Announces Approval For Marketing of Naldemedine For Opioid-Induced Constipation In Adults	CI

Insiders

29/04	Sino Biopharmaceutical Limited Announces Board and Committee Changes	CI
28/04	Sino Biopharmaceutical Limited Announces Executive Appointments	CI
23/01	Sino Biopharma CEO on China's Rapid Clinical Trial Growth	MT
14/01	Sino Biopharm To Remain Active in M&A, Says Chair	MT
13/01	Sino Biopharmaceutical Limited Announces Executive Changes, Effective January 13, 2026	CI
23/25/23	Sino Biopharm CEO Eric Tse on Outlook, Asian Pharmaceutical Market & Trump	MT
21/24/21	Sino Biopharmaceutical Completes Issuance of 1.5 Billion Yuan in Panda Bonds	MT
05/24/05	Sino Biopharmaceutical Limited Announces Retirement of Ms. Li Mingqin as Executive Director	CI
02/22/02	Sino Biopharmaceutical Limited Announces Resignation of Wang Shanchun as Executive Director	CI
28/22/28	Sino Biopharmaceutical CEO Resigns	MT
27/22/27	Sino Biopharmaceutical Limited Announces CEO Changes, Effective July 28, 2022	CI
27/22/27	Sino Biopharmaceutical Limited Announces Resignation of Li Yi as Executive Director	CI
10/21/10	Sino Biopharmaceutical Limited Appoints Mao Li as Chief Medical Officer	CI
31/20/31	Sino Biopharmaceutical Limited Appoints Li Kwok Tung Donald as an Independent Non-Executive Director and a Member of the Audit Committee and Nomination Committee	CI
21/20/21	Sino Biopharmaceutical Limited Announces Executive Changes	CI
21/20/21	Sino Biopharmaceutical Limited Announces Management Changes	CI
23/19/23	Sino Biopharmaceutical Limited Appoints Tse, Eric S Y as an Executive Director and Member of the Executive Board Committee	CI
10/17/10	Sino Biopharmaceutical Limited Appoints Cheng Cheung Ling as an Executive Director, the Vice Chairlady of the Board, and Member of the Executive Board Committee	CI
29/16/29	Sino Biopharmaceutical Limited Announces Management Changes	CI
26/15/26	Sino Biopharmaceutical Limited Announces Resignation of Ms. Cheng Cheung Ling as an Executive Director	CI
25/15/25	Sino Biopharmaceutical Limited Announces Board Changes	CI
30/15/30	Sino Biopharmaceutical Ltd. Announces Board Changes	CI
20/15/20	Sino Biopharmaceutical Ltd. Announces Management Changes	CI
30/12/30	Sino Biopharmaceutical Ltd. Reports Consolidated Earnings Results for the Year Ended December 31, 2011; Recommends Final Dividend, Payable on June 18, 2012; Announces Management Changes	CI